Company Details
gilead-sciences
14,605
792,598
541714
gilead.com
245
GIL_6922720
Completed


Gilead Sciences Vendor Cyber Rating & Cyber Score
gilead.comAt Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
Company Details
gilead-sciences
14,605
792,598
541714
gilead.com
245
GIL_6922720
Completed
Between 800 and 849

Gilead Sciences Global Score (TPRM)XXXX

Description: On April 2, 2025, the Maine Office of the Attorney General disclosed a data breach involving Gilead Sciences, Inc., stemming from an inadvertent mailing error by Billing Document Specialists. The incident, detected on February 18, 2025, resulted in the unauthorized disclosure of sensitive personal information specifically Social Security numbers of 12,224 individuals, including 4 residents in California. The breach occurred due to a procedural failure in handling physical mail, leading to the exposure of confidential financial identifiers without evidence of malicious cyber activity or further exploitation. While the exposed data carries high sensitivity, there were no reports of identity theft, financial fraud, or systemic compromise linked to the incident. The company likely initiated remediation measures, such as notifications to affected parties and regulatory bodies, but the breach’s scope remained contained to document mishandling rather than a targeted cyberattack or systemic vulnerability exploitation.
Description: The employees of drugmaker company Gilead Sciences were targeted by some hackers linked to Iran. The web domains and hosting servers and fake email logins were used to compromise the company's servers.


No incidents recorded for Gilead Sciences in 2026.
No incidents recorded for Gilead Sciences in 2026.
No incidents recorded for Gilead Sciences in 2026.
Gilead Sciences cyber incidents detection timeline including parent company and subsidiaries

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built f

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions s
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global heal

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v
.png)
Boulder Ventures, founded in the 1980s by Baltimore lawyers Larry Macks and Josh Fidler, has joined a $42 million Series A for RapidFort,...
On January 12, 2026, the Department of Justice (DOJ) announced that False Claims Act (FCA) settlements and judgments exceeded $6.8 billion...
Gilead Sciences shares closed at $121.22 on December 5, 2025, about 6% below their 52-week high.
As of 6 December 2025, BlackBerry Limited (NYSE: BB; TSX: BB) is back on many traders' and long‑term investors' watchlists.
Here's why analysts believe Gilead Sciences (NASDAQ: GILD) could see about 3% upside by 2027, driven by steady HIV growth, new drug launches...
Gilead invests in world-class science and is pursuing innovation across the therapeutic areas of virology, oncology and inflammation.
FDA approves Gilead Sciences' groundbreaking HIV prevention injection, Yeztugo, with 99.9% effectiveness, but high cost raises concerns.
With the acceleration of digital transformation, the cyber talent gap has widened to a chasm. According to the most recent Cybersecurity Workforce Study by...
The aim of the collaboration is to deliver better cost leadership, productivity enhancement and elicit greater value from the existing...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Gilead Sciences is http://www.gilead.com.
According to Rankiteo, Gilead Sciences’s AI-generated cybersecurity score is 804, reflecting their Good security posture.
According to Rankiteo, Gilead Sciences currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Gilead Sciences has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
According to Rankiteo, Gilead Sciences is not certified under SOC 2 Type 1.
According to Rankiteo, Gilead Sciences does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Gilead Sciences is not listed as GDPR compliant.
According to Rankiteo, Gilead Sciences does not currently maintain PCI DSS compliance.
According to Rankiteo, Gilead Sciences is not compliant with HIPAA regulations.
According to Rankiteo,Gilead Sciences is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Gilead Sciences operates primarily in the Biotechnology Research industry.
Gilead Sciences employs approximately 14,605 people worldwide.
Gilead Sciences presently has no subsidiaries across any sectors.
Gilead Sciences’s official LinkedIn profile has approximately 792,598 followers.
Gilead Sciences is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
Yes, Gilead Sciences has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/gilead-sciences.
Yes, Gilead Sciences maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/gilead-sciences.
As of April 02, 2026, Rankiteo reports that Gilead Sciences has experienced 2 cybersecurity incidents.
Gilead Sciences has an estimated 4,635 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.
Detection and Response: The company detects and responds to cybersecurity incidents through an communication strategy with public disclosure via maine office of the attorney general..
Title: Cyber Attack on Gilead Sciences by Iran-Linked Hackers
Description: The employees of drugmaker company Gilead Sciences were targeted by some hackers linked to Iran. The web domains and hosting servers and fake email logins were used to compromise the company's servers.
Type: Cyber Attack
Attack Vector: Phishing, Server Compromise
Threat Actor: Iran-Linked Hackers
Title: Gilead Sciences, Inc. Data Breach via Mailing Error
Description: The Maine Office of the Attorney General reported a data breach involving Gilead Sciences, Inc. The breach occurred due to an inadvertent disclosure of 12,224 individuals' information, including Social Security numbers, through a mailing error by Billing Document Specialists. The incident affected 4 residents in California.
Date Detected: 2025-02-18
Date Publicly Disclosed: 2025-04-02
Type: Data Breach
Attack Vector: Human Error (Mailing Error)
Common Attack Types: The most common types of attacks the company has faced is Breach.
Identification of Attack Vectors: The company identifies the attack vectors used in incidents through Fake Email Logins.

Systems Affected: Servers

Data Compromised: Social security numbers
Brand Reputation Impact: Potential reputational harm due to exposure of sensitive personal data
Identity Theft Risk: High (due to exposure of Social Security numbers)
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Social Security Numbers and .

Entity Name: Gilead Sciences
Entity Type: Company
Industry: Pharmaceuticals

Entity Name: Gilead Sciences, Inc.
Entity Type: Corporation
Industry: Biopharmaceutical
Location: United States
Customers Affected: 12,224 individuals (including 4 residents in California)

Entity Name: Billing Document Specialists
Entity Type: Third-Party Vendor
Industry: Document Processing

Communication Strategy: Public disclosure via Maine Office of the Attorney General

Type of Data Compromised: Social security numbers
Number of Records Exposed: 12,224
Sensitivity of Data: High (Personally Identifiable Information)
Data Exfiltration: No (inadvertent disclosure via mailing error)
Personally Identifiable Information: Yes

Regulatory Notifications: Maine Office of the Attorney General

Source: Maine Office of the Attorney General
Date Accessed: 2025-04-02
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: Maine Office of the Attorney GeneralDate Accessed: 2025-04-02.
Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through Public disclosure via Maine Office of the Attorney General.

Entry Point: Fake Email Logins,

Root Causes: Human error by third-party vendor (Billing Document Specialists) leading to inadvertent disclosure of sensitive data via mail.
Last Attacking Group: The attacking group in the last incident was an Iran-Linked Hackers.
Most Recent Incident Detected: The most recent incident detected was on 2025-02-18.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2025-04-02.
Most Significant Data Compromised: The most significant data compromised in an incident were Social Security numbers and .
Most Significant System Affected: The most significant system affected in an incident was Servers.
Most Sensitive Data Compromised: The most sensitive data compromised in a breach was Social Security numbers.
Number of Records Exposed in Most Significant Breach: The number of records exposed in the most significant breach was 12.2K.
Most Recent Source: The most recent source of information about an incident is Maine Office of the Attorney General.
.png)
A vulnerability was found in Nothings stb up to 1.26. Impacted is the function stbtt_InitFont_internal in the library stb_truetype.h of the component TTF File Handler. Performing a manipulation results in out-of-bounds read. Remote exploitation of the attack is possible. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.
V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read in VS6ComFile!get_macro_mem_COM. Opening a crafted V7 file may lead to information disclosure from the affected product.
V-SFT versions 6.2.10.0 and prior contain a stack-based buffer overflow in VS6ComFile!CSaveData::_conv_AnimationItem. Opening a crafted V7 file may lead to arbitrary code execution on the affected product.
V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read vulnerability in VS6MemInIF!set_temp_type_default. Opening a crafted V7 file may lead to information disclosure from the affected product.
V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read vulnerability in VS6ComFile!load_link_inf. Opening a crafted V7 file may lead to information disclosure from the affected product.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.